The efficacy of ribavirin in Crimean-Congo hemorrhagic fever--randomized trials are urgently needed

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Medipol University, Istanbul, Turkey. Electronic address: bceylan2004@yahoo.com.
² Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.

Free article

Comment

Bahadır Ceylan et al. Int J Infect Dis. 2014 Dec.

Free article

. 2014 Dec:29:297-8.

doi: 10.1016/j.ijid.2014.08.015. Epub 2014 Oct 18.

¹ Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Medipol University, Istanbul, Turkey. Electronic address: bceylan2004@yahoo.com.
² Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.

No abstract available

Comment on

Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
Ceylan B, Calıca A, Ak O, Akkoyunlu Y, Turhan V. Ceylan B, et al. Int J Infect Dis. 2013 Oct;17(10):e799-801. doi: 10.1016/j.ijid.2013.02.030. Epub 2013 Jun 15. Int J Infect Dis. 2013. PMID: 23773242 Free PMC article.
Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever.
Ergonul O. Ergonul O. Int J Infect Dis. 2014 Dec;29:296. doi: 10.1016/j.ijid.2014.08.016. Epub 2014 Oct 22. Int J Infect Dis. 2014. PMID: 25461237 No abstract available.